NMPA Approval

Trilaciclib Hydrochloride for Injection

Approval Number

国药准字H20247315

Company海南先声药业有限公司

Registration Date

December 11, 2024

Previous Approval Numbers

国药准字H20237181

Drug Information

Generic Name

注射用盐酸曲拉西利

Dosage Form

注射剂

Strength

100mg (按C₂₄H₃₀N₈O计)

Drug Type

化学药品

Registration Date

December 11, 2024

Company Information

Applicant Company

Company Name海南先声药业有限公司

Company Address

海南省海口市秀英区药谷三路2号

Manufacturing Company

Company Name海南先声药业有限公司

Company Address

海南省海口市秀英区药谷三路2号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸曲拉西利 - NMPA 批准文号 | MedPath